Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
W Zhu, Z Ye, S Chen, D Wu, J He, Y Dong, GYH Lip… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
[HTML][HTML] Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic …
G Ntaios, V Papavasileiou, K Makaritsis, K Vemmos… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Evidence from the real-world setting complements evidence
coming from randomized controlled trials. We aimed to summarize all available evidence …
coming from randomized controlled trials. We aimed to summarize all available evidence …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Comparative effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
Background There are no head-to-head randomized controlled trials comparing different
direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed …
direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed …
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham, LR Sangaralingham… - Journal of the …, 2016 - Am Heart Assoc
Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Comparative safety and effectiveness of oral anticoagulants in nonvalvular atrial fibrillation: the Naxos study
E Van Ganse, N Danchin, I Mahé, O Hanon, F Jacoud… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: The effects of direct oral anticoagulants in nonvalvular atrial
fibrillation should be assessed in actual conditions of use. France has near-universal …
fibrillation should be assessed in actual conditions of use. France has near-universal …
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 …
P Archontakis‐Barakakis, W Li… - British Journal of …, 2022 - Wiley Online Library
Aims Observational studies have investigated the effectiveness and safety of direct oral
anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial …
anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial …
Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients: the ARISTOPHANES study
Background and Purpose—This ARISTOPHANES study (Anticoagulants for Reduction in
Stroke: Observational Pooled Analysis on Health Outcomes and Experience of Patients) …
Stroke: Observational Pooled Analysis on Health Outcomes and Experience of Patients) …
Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and previous stroke or transient …
CI Coleman, WF Peacock, TJ Bunz, MJ Alberts - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Limited real-world data exist comparing each non–vitamin K
antagonist oral anticoagulant (NOAC) to warfarin in patients with nonvalvular atrial …
antagonist oral anticoagulant (NOAC) to warfarin in patients with nonvalvular atrial …
相关搜索
- atrial fibrillation meta analysis
- atrial fibrillation effectiveness and safety
- oral anticoagulants fibrillation patients
- oral anticoagulants effectiveness and safety
- warfarin in patients effectiveness and safety
- dabigatran rivaroxaban effectiveness and safety
- atrial fibrillation dabigatran rivaroxaban
- atrial fibrillation stroke prevention
- oral anticoagulants stroke prevention
- oral anticoagulants meta analysis
- meta analysis effectiveness and safety
- oral anticoagulants setting comparison
- intracranial events effectiveness and safety
- previous stroke effectiveness and safety
- atrial fibrillation intracranial events
- atrial fibrillation setting comparison